DK Life Science Co., Ltd. (KOSDAQ:303810)
South Korea · Delayed Price · Currency is KRW 2,225.00
+5.00 (0.23%)
Sep 14, 2026, 1:51 PM KST
DK Life Science Market Cap
DK Life Science has a market cap or net worth of 71 billion as of September 11, 2026. Its market cap has decreased by -48.97% in one year.
Market Cap
71.00B
Enterprise Value
100.48B
Revenue
117.75B
Ranking
n/a
PE Ratio
14.32
Stock Price
2,225.00
ChartMarket Cap Chart
Since February 17, 2025, DK Life Science's market cap has decreased from 200.38B to 71.00B, a decrease of -64.57%. That is a compound annual growth rate of -48.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 71.00B | -39.34% |
| Dec 30, 2025 | 117.06B | -41.58% |
| Feb 17, 2025 | 200.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.43T |
| Celltrion | 42.77T |
| ALTEOGEN | 18.66T |
| Samsung Epis Holdings | 8.44T |
| CG Invites | 73.28B |
| DRTECH | 72.96B |
| Ray Co., Ltd. | 72.49B |
| CKD Bio | 71.43B |